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Niger: Meningitis
ABOUT THE NATION
Niger is located in western Africa. The total area is
1.267 million sq km. 1.266.700 sq km of land and 300 sq
km of water and 0 km of coastline. The majority of the
population lives isolated in the most extreme southern part
of the country, along the border with Nigeria and Benin.
The capital is Niamey. The climate is mostly hot and dry.
The total population is 19,245,344 (July 2017 est.).
1.09 million people lives in the capital Niamey. Different
ethnic groups live in Niger: Hausa, Zarma/Songhai,Tuareg,
Fulani(Peul), Kanuri, Gurma, Arab, Tubu and others.
The official language is French. 80% of the population
is Muslim. Population is predominantly male and the
refugees’ population is about 180 thousand people (108,470
from Nigeria and 57,286 from Mali).

Figure1.Location of the study area, Niger. This area comprises the
379 health areas in 3 regions (Tahoua, Tillabery, and Dosso).
Maïnassara, H. B., Paireau, J., Idi, I., Pelat, J. M., Oukem-Boyer, O.
M., Fontanet, A., & Mueller, J. E. (2015).

Niger is a semi-presidential republic in which the
president is elected by absolute majority of votes
in 2 rounds, if needed. The president is
Mahamadou Issoufou, since 2011. It is a 5-year
term (eligible for second term). Ambassador
Hassana Alidou is responsible for the
representation in the US. Ambassador Eunice S.
Reddick is responsible for the representation from
the US.
About 80% of Niger’s territory is occupied by
the Sahara Desert. The desert has been spreading
in recent years, forcing farmers to go away from
their lands. Most of Niger’s population survives
because of their subsistence farms.
Niger has a 1.608 thousand km border with
Nigeria, country that has being suffering with a
terrible Meningitis A outbreak since 2015. Niger is
located in the Meningitis belt. The Meningitis belt
of sub-Saharan Africa is the place with the highest
burden of the disease, stretching from Senegal in
the west to Ethiopia in the east. 30 000 cases are
reported in that area every year.
Niger has been suffering with Libya claiming
25,000 sq km of the territory located in the Tommo
region (located in the Chad-Niger-Nigeria
boundaries.
Refugees are responsible for internal conflict;
11,000 people have been displaced because of the
conflict between government forces and the
Tuareg militant group.

ABOUT THE PUBLIC HEALTH ISSUE

PREVENTION

Meningitis or Menigococcal Disease (MD) is caused
by a bacterium called Neisseria meningitides. MD is
an inflammation of the brain and some of the effects of
the condition are: deafness, light sensitivity, severe
headache. MD is fatal in 50-80% of untreated cases. In
treated cases the fatality rates are 10-15%. Sequelae is
present in 12-20% of the survivors. The most common
sequelae are the neuropsychological sequelae, like
hearing loss. Sequelae are the result of the damage
caused by the condition.
In the big outbreak in 2015, 12 thousand cases of
meningitis C were registered in Niger and Nigeria, 800
died. The most affected groups were infants, less than
1 year old. There are peaks of incidence seen in
adolescents and elderly in some countries. According
to CDC some of the risk factors are: age, community
settings, travel.
A really important thing to notice when trying to
identify meningitis is ask the patient to put the chin in
the chest; for people that have MD this is practically
impossible. It is really hard to have an early diagnose
because the symptoms are similar to other illnesses.

The prevention attempted was vaccines, and it was
really effective, serogroup A was eliminated in 3 regions
in Niger. The cost of the whole surveillance system in
Niger was US$ 1,951,562. The cost was expensive
because strengthened surveillance was required. The
most effective prevention is vaccination. In June of 2015
220 million people have been vaccinated in 16 African
countries, including Niger. Price was around US$ 0.50
per dose. WHO sent 341,000 doses of the vaccine to
Niger.

Fig. 2. Comparison of Niger's current and upgrading cost of
meningitis surveillance, US$. *IEC stands for information,
education and communication.
Irurzun-Lopez, Maite., A. Erondu, Ngozi, Djibo., Ali…,
Colombini, Anaïs (2016).

SOLUTION
The solution that has been used to prevent
Meningitis to spread even more after the 2015
outbreak is vaccination. The price is 0.50 US$.
With the recent spread of the Sahara-desert
farmers have been leaving their subsistence
farms, most of Niger’s population live with
less than 1 US$/day (CIA, 2017). Even more
people could be vaccinated if those that do not
have enough money to pay could be vaccinated
without being charged.
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